Astrantus »

Pacific Biosciences of California shares owned by Astrantus

Quarter-by-quarter ownership of Pacific Biosciences of California (PACB) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Pacific Biosciences of California

Tip: Access up to 7 years of quarterly data

All positions including Pacific Biosciences of California held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacific Biosciences of California by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $116k 13k 9.13

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Pacific Biosciences of California

ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Bank of New York Mellon
Jackson Square Partners
Bellevue Group
Point72 Asset Management
T. Rowe Price Associates
Dimensional Fund Advisors
Decheng Capital
VK Services
Lord, Abbett & Co
Charles Schwab Investment Management
Iron Triangle Partners

View all funds holding Pacific Biosciences of California